Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Comments on the 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Ischaemic heart disease, infection, and treatment of infection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Jessica E Potts
  • Cezar A Iliescu
  • Juan C Lopez Mattei
  • Sara C Martinez
  • Lene Holmvang
  • Peter Ludman
  • Mark A De Belder
  • Chun Shing Kwok
  • Muhammad Rashid
  • David L Fischman
  • Mamas A Mamas
Vis graf over relationer

Aims: This study aims to examine the temporal trends and outcomes in patients who undergo percutaneous coronary intervention (PCI) with a previous or current diagnosis of cancer, according to cancer type and the presence of metastases.

Methods and results: Individuals undergoing PCI between 2004 and 2014 in the Nationwide Inpatient Sample were included in the study. Multivariable analyses were used to determine the association between cancer diagnosis and in-hospital mortality and complications. 6 571 034 PCI procedures were included and current and previous cancer rates were 1.8% and 5.8%, respectively. Both rates increased over time and the four most common cancers were prostate, breast, colon, and lung cancer. Patients with a current lung cancer had greater in-hospital mortality (odds ratio (OR) 2.81, 95% confidence interval (95% CI) 2.37-3.34) and any in-hospital complication (OR 1.21, 95% CI 1.10-1.36), while current colon cancer was associated with any complication (OR 2.17, 95% CI 1.90-2.48) and bleeding (OR 3.65, 95% CI 3.07-4.35) but not mortality (OR 1.39, 95% CI 0.99-1.95). A current diagnosis of breast was not significantly associated with either in-hospital mortality or any of the complications studied and prostate cancer was only associated with increased risk of bleeding (OR 1.41, 95% CI 1.20-1.65). A historical diagnosis of lung cancer was independently associated with an increased OR of in-hospital mortality (OR 1.65, 95% CI 1.32-2.05).

Conclusions: Cancer among patients receiving PCI is common and the prognostic impact of cancer is specific both for the type of cancer, presence of metastases and whether the diagnosis is historical or current. Treatment of patients with a cancer diagnosis should be individualized and involve a close collaboration between cardiologists and oncologists.

TidsskriftEuropean Heart Journal
Udgave nummer22
Sider (fra-til)1790-1800
Antal sider11
StatusUdgivet - 7 jun. 2019

ID: 56431276